What Philip Morris Seeks in FDA Regulation: Preservation of the Status Quo
A 23-page, formerly "privileged and confidential" company [http://legacy.library.ucsf.edu/tid/lgs32a00 discussion document] outlines [[Philip Morris]]' thinking behind its 180-degree turn from strongly opposing U.S. Food and Drug Administration (FDA) of cigarettes to in fact driving such regulation. It clues us in to the company's logic in proceeding down this path and what the company hopes for and fears most in FDA regulation. It was written by Mark Berlind, who was Assistant General Counsel of Philip Morris Worldwide Regulatory Affairs in 1998.
Berlind recaps PM's history of opposing FDA regulation and recommends that PM USA advocate for regulation instead as a way to maintain the status quo, or "perpetuate the existing framework's philosophy that adults continue to be permitted to assume" the inherent risks of cigarette smoking. Berlind supported the: